002793 Luoxin Pharmaceuticals Group Stock
- 4.27
- -0.08-1.84%
Luoxin Pharmaceuticals Group Stock News
Luo Xin Pharmaceutical: Simplified Equity Change Report (2)
Luo Xin Pharmaceutical: Simplified Equity Change Report (1)
Luoxin Pharmaceutical: An indicative announcement on changes in shareholders\' total shareholders\' agreement to transfer the company\'s shares and equity
Luoxin Pharmaceuticals Group Stock: Announcement on Supplementary Disclosure of Agreements Related to Transfer of Equity Interest in Subsidiaries Under Control
Luoxin Pharmaceuticals Group Stock: Announcement on the progress of the transfer of shares in the holding subsidiary
Luoxin Pharmaceutical: Announcement on completion of share repurchase and share changes
Luoxin Pharmaceutical: Announcement on the share repurchase ratio reaching 2% and the progress of the repurchase
Luoxin Pharmaceutical: Announcement on the share repurchase ratio reaching 1% and the progress of the repurchase
Luoxin Pharmaceutical: Announcement on the initial repurchase of the company\'s shares
Luoxin Pharmaceutical: Repurchase Report
Luoxin Pharmaceutical: Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for share repurchases
Luoxin Pharmaceutical: Announcement on the share repurchase plan
Luoxin Pharmaceutical: An indicative announcement on the lifting of sales restrictions on some restricted shares
Luo Xin Pharmaceutical: Notice on the unanimous actions of shareholders holding 5% or more of the shares and not reducing their holdings at the end of the plan period
Luo Xin Pharmaceutical: Notice on the voluntary commitment of the controlling shareholders and their co-actors not to reduce their holdings of the company\'s shares
Luoxin Pharmaceutical: Announcement on the change in the total shareholding ratio of the controlling shareholder and those acting in concert by more than 1%
Luoxin Pharmaceutical: Prompt Announcement on Changes in the Rights and Interests of Controlling Shareholders and Their Coordinating Actors
Luo Xin Pharmaceutical: Simplified Report on Changes in Equity
Luoxin Pharmaceutical: Announcement on the progress of the plan to reduce the holdings of co-actor shares held by more than 5% of the shareholders over half of the time
Luoxin Pharmaceutical: Announcement on the progress of forming financial support after transferring shares in holding subsidiaries
Analysis
Price Target
No Data
No Data